(E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway

Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer

(2013) Teng Ji et al.   CANCER LETTERS

Ovarian Cancer Stem Cells: A New Target for Cancer Therapy

(2013) Qinglei Zhan et al.   Biomed Research International

AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules

(2012) Mi-Kyung Hwang et al.   AMINO ACIDS

Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor κB and signal transducer and activator of transcription 3

(2012) Ju Kyoung Song et al.   ARCHIVES OF PHARMACAL RESEARCH

(E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5)

(2012) Pushpa Saranya Kollipara et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer

(2011) Zhiqiang Han et al.   HUMAN GENE THERAPY

Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells

(2011) Young-Jung Lee et al.   Journal of Neuroinflammation

Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway

(2011) Miran Jo et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Survival of patients with ovarian cancer in central and northern Denmark, 1998–2009

(2011) Grann et al.   Clinical Epidemiology

Ovarian Cancer: Opportunity for Targeted Therapy

(2011) Tomoko Tagawa et al.   Journal of Oncology

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

(2009) Bharat B. Aggarwal et al.   Annals of the New York Academy of Sciences

Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG

(2009) A. K. Ghosh et al.   CLINICAL CANCER RESEARCH

Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor- B activity via direct interaction with p50

(2009) J. O. Ban et al.   MOLECULAR CANCER THERAPEUTICS

Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells

(2008) Hui Xing et al.   CANCER LETTERS

Targeting TRAIL death receptors

(2008) CNAM Oldenhuis et al.   CURRENT OPINION IN PHARMACOLOGY

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols

(2008) Anna Bratasz et al.   Journal of Translational Medicine